Clinical Trial Update: AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for AVA6103 in patients with locally advanced or metastatic selected solid tumors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Vulva
• Cervical Adenocarcinoma
• Cervical Adenosquamous Carcinoma
• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma
• Pancreatic Ductal Adenocarcinoma
• Small Cell Lung Cancer

Drugs mentioned

• AVA6103

Snippet

Sponsor: Avacta Life Sciences Ltd | Conditions: Vulvar Adenocarcinoma, PDAC - Pancreatic Ductal Adenocarcinoma | Phase 1 | Status: RECRUITING